Search Results - "Kamel, Amany O"

Refine Results
  1. 1

    Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies by Salah, Salwa, Mahmoud, Azza A., Kamel, Amany O.

    Published in Drug delivery (2017)
    “…In this study, transdermal etodolac-loaded cubosomes were developed in order to relieve patient pain and joints stiffness by providing stable etodolac…”
    Get full text
    Journal Article
  2. 2

    Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment by Hatem, Shymaa, Elkheshen, Seham A., Kamel, Amany O., Nasr, Maha, Moftah, Noha H., Ragai, Maha H, Elezaby, Reham S., El Hoffy, Nada M.

    Published in Drug delivery (01-12-2022)
    “…The increase in the production of melanin level inside the skin prompts a patient-inconvenient skin color disorder namely; melasma. This arouses the need to…”
    Get full text
    Journal Article
  3. 3

    Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution by Ishak, Rania A. H., Mostafa, Nada M., Kamel, Amany O.

    Published in Drug delivery (2017)
    “…The blood-brain barrier is considered the leading physiological obstacle hindering the transport of neurotherapeutics to brain cells. The application of…”
    Get full text
    Journal Article
  4. 4

    Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system by Kamel, Amany O, Mahmoud, Azza A

    Published in Journal of biomedical nanotechnology (01-01-2013)
    “…The purpose of this study was to develop spray dried self-nanoemulsifying drug delivery system (SNEDDS) tablets of rosuvastatin using mannitol as a carrier…”
    Get more information
    Journal Article
  5. 5

    Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan by Mekhail, George M., Kamel, Amany O., Awad, Gehanne A.S., Mortada, Nahed D.

    “…The purpose of this study was to develop a new therapeutic approach for atorvastatin (ATV) adopting nanostructured polymeric micelles for its controlled…”
    Get full text
    Journal Article
  6. 6

    Nanosized particulate systems for dermal and transdermal delivery by Hassan, Amany O Kamel, Elshafeey, Ahmed H

    Published in Journal of biomedical nanotechnology (01-12-2010)
    “…Nanosized particles have received much attention in industry, biology, and medicine. Today nanotechnology is finding growing applications in pharmaceutical…”
    Get more information
    Journal Article
  7. 7

    Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs by Youshia, John, Kamel, Amany O., El Shamy, Abdelhameed, Mansour, Samar

    “…Solid lipid nanoparticles and nanostructured lipid carriers showed promising results for enhancement of ocular bioavailability of drugs with poor corneal…”
    Get full text
    Journal Article
  8. 8

    Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route by Gabal, Yasmine M., Kamel, Amany O., Sammour, Omaima A., Elshafeey, Ahmed H.

    Published in International journal of pharmaceutics (01-10-2014)
    “…[Display omitted] The aim of this study was to investigate the influence of the nanocarrier surface charge on brain delivery of a model hydrophilic drug via…”
    Get full text
    Journal Article
  9. 9

    An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension by Zayed, Reham, Kamel, Amany O., Shukr, Marwa, El-Shamy, Abd El-Hamid

    Published in Acta pharmaceutica (Zagreb, Croatia) (01-09-2012)
    “…Sildenafilcitrate (SILD) orodispersable sublingual tablets (ODSTs) have been developed using two comparative techniques for improving their oral…”
    Get full text
    Journal Article
  10. 10

    Interactions between DNA and Gemini surfactant: impact on gene therapy: part I by Ahmed, Taksim, Kamel, Amany O, Wettig, Shawn D

    Published in Nanomedicine (01-02-2016)
    “…Nonviral gene therapy using gemini surfactants is a unique approach to medicine that can be adapted toward the treatment of various diseases. Recently, gemini…”
    Get full text
    Journal Article Book Review
  11. 11

    Novel green-based polyglycerol polymeric nanoparticles loaded with ferulic acid: A promising approach for hepatoprotection by Mahmoud, Mariam H., El-Gogary, Riham I., Soliman, Mahmoud E., Kamel, Amany O.

    “…In the pursuit of eco-friendly and sustainable materials, polyglycerol diacid polymers hold immense promise for drug delivery compared to those derived from…”
    Get full text
    Journal Article
  12. 12

    Injectable long acting chitosan/tripolyphosphate microspheres for the intra-articular delivery of lornoxicam: Optimization and in vivo evaluation by Abd-Allah, Hend, Kamel, Amany O., Sammour, Omaima A.

    Published in Carbohydrate polymers (20-09-2016)
    “…•Lornoxicam loaded chitosan/TPP microspheres prepared with ionotropic gelation for intra-articular delivery.•Formulation variables were optimized using full…”
    Get full text
    Journal Article
  13. 13

    Ethyl lauroyl arginate-based hydrophobic ion pair complex in lipid nanocapsules: A novel oral delivery approach of rosmarinic acid for enhanced permeability and bioavailability by Gad, Heba A., Ishak, Rania A.H., Labib, Rola M., Kamel, Amany O.

    Published in International journal of pharmaceutics (05-01-2023)
    “…[Display omitted] Limited oral bioavailability due to high hydrophilicity restricts the beneficial use of Rosmaranic acid (RM) that is characterized by many…”
    Get full text
    Journal Article
  14. 14

    Nano-vesicular systems for melanocytes targeting and melasma treatment: In-vitro characterization, ex-vivo skin retention, and preliminary clinical appraisal by Hatem, Shymaa, Kamel, Amany O., Elkheshen, Seham A., Nasr, Maha, Moftah, Noha H., Ragai, Maha H., El Hoffy, Nada M., Elezaby, Reham S.

    Published in International journal of pharmaceutics (15-11-2024)
    “…[Display omitted] •Vesicular systems have the ability to transfer α-arbutin to various skin layers and to act as depots.•α-arbutin nanovesicles containing…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation by AbdelSamie, Sara M., Kamel, Amany O., Sammour, Omaima A., Ibrahim, Shady M.

    “…In this work, nanovesicular chitosan gels were prepared for dermal delivery of terbinafine hydrochloride (TBN HCl). Ethosomes and vesicles containing different…”
    Get full text
    Journal Article
  17. 17

    Interactions between DNA and gemini surfactant: impact on gene therapy: part II by Ahmed, Taksim, Kamel, Amany O, Wettig, Shawn D

    Published in Nanomedicine (01-02-2016)
    “…Nonviral gene delivery, provides distinct treatment modalities for the inherited and acquired diseases, relies upon the encapsulation of a gene of interest,…”
    Get full text
    Journal Article Book Review
  18. 18

    A natural protein based platform for the delivery of Temozolomide acid to glioma cells by Helal, Dina O., Rouatbi, Nadia, Han, Shunping, Tzu-Wen Wang, Julie, Walters, Adam A., Abdel-Mottaleb, Mona M.A., Kamel, Amany O., Geneidi, Ahmed-Shawky, Awad, Gehanne A.S., Al-Jamal, Khuloud T.

    “…Proposed hypothesis in this study. Brain tumours overexpress SPARC protein which is responsible for the uptake of albumin nanoparticles (HSA NPs). Temozolomide…”
    Get full text
    Journal Article
  19. 19

    The interplay of solvent–drug–protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells by Helal, Dina O, Abdel-Mottaleb, Mona M A, Kamel, Amany O, Rouatbi, Nadia, Han, Shunping, Geneidi, Ahmed-Shawky, Al-Jamal, Khuloud T, Awad, Gehanne A S

    Published in Journal of pharmacy and pharmacology (05-07-2023)
    “…Abstract Objectives Temozolomide (TMZ), the first line for glioma therapy, suffers from stability at physiological pH. TMZ was selected as a challenging model…”
    Get full text
    Journal Article
  20. 20

    Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route by Salama, Hamed A., Mahmoud, Azza A., Kamel, Amany O., Abdel Hady, Mayssa, Awad, Gehanne A.S.

    Published in Colloids and surfaces, B, Biointerfaces (01-12-2012)
    “…[Display omitted] ► New phospholipid based nanocubic vesicular systems were developed. ► The polymeric non-ionic surfactant, poloxamer was incorporated in its…”
    Get full text
    Journal Article